125 related articles for article (PubMed ID: 38848179)
1. Exploring the Association Between Visual Field Testing and CERAD Neuropsychological Battery in Idiopathic Normal Pressure Hydrocephalus Patients.
Kemiläinen B; Tiainen S; Rauramaa T; Luikku AJ; Herukka SK; Koivisto A; Hiltunen M; Verdooner S; Johnson K; Chambers M; Kaarniranta K; Leinonen V
J Alzheimers Dis; 2024; 100(1):247-260. PubMed ID: 38848179
[TBL] [Abstract][Full Text] [Related]
2. The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
Nerg O; Junkkari A; Hallikainen I; Rauramaa T; Luikku A; Hiltunen M; Jääskeläinen JE; Leinonen V; Hänninen T; Koivisto A
J Alzheimers Dis; 2021; 81(3):1117-1130. PubMed ID: 33896842
[TBL] [Abstract][Full Text] [Related]
3. CERAD-neuropsychological battery in screening mild Alzheimer's disease.
Sotaniemi M; Pulliainen V; Hokkanen L; Pirttilä T; Hallikainen I; Soininen H; Hänninen T
Acta Neurol Scand; 2012 Jan; 125(1):16-23. PubMed ID: 21198445
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus.
Kamohara C; Nakajima M; Kawamura K; Akiba C; Ogino I; Xu H; Karagiozov K; Arai H; Miyajima M
Acta Neurol Scand; 2020 Dec; 142(6):623-631. PubMed ID: 32619270
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.
Kanemoto H; Mori E; Tanaka T; Suehiro T; Yoshiyama K; Suzuki Y; Kakeda K; Wada T; Hosomi K; Kishima H; Kazui H; Hashimoto M; Ikeda M
Int Psychogeriatr; 2023 Sep; 35(9):509-517. PubMed ID: 34399871
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
[TBL] [Abstract][Full Text] [Related]
7. Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.
Akiba C; Nakajima M; Miyajima M; Ogino I; Motoi Y; Kawamura K; Adachi S; Kondo A; Sugano H; Tokuda T; Irie K; Arai H
J Alzheimers Dis; 2018; 63(3):989-1002. PubMed ID: 29710721
[TBL] [Abstract][Full Text] [Related]
8. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
[TBL] [Abstract][Full Text] [Related]
9. Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status.
Niermeyer M; Gaudet C; Malloy P; Piryatinsky I; Salloway S; Klinge P; Lee A
J Int Neuropsychol Soc; 2020 Oct; 26(9):883-893. PubMed ID: 32430087
[TBL] [Abstract][Full Text] [Related]
10. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
11. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
Stein J; Luppa M; Luck T; Maier W; Wagner M; Daerr M; van den Bussche H; Zimmermann T; Köhler M; Bickel H; Mösch E; Weyerer S; Kaufeler T; Pentzek M; Wiese B; Wollny A; König HH; Riedel-Heller SG
Am J Geriatr Psychiatry; 2012 Jan; 20(1):84-97. PubMed ID: 22183013
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers.
Lim TS; Choi JY; Park SA; Youn YC; Lee HY; Kim BG; Joo IS; Huh K; Moon SY
BMC Neurol; 2014 Apr; 14():66. PubMed ID: 24690253
[TBL] [Abstract][Full Text] [Related]
13. Default mode network connectivity in patients with idiopathic normal pressure hydrocephalus.
Khoo HM; Kishima H; Tani N; Oshino S; Maruo T; Hosomi K; Yanagisawa T; Kazui H; Watanabe Y; Shimokawa T; Aso T; Kawaguchi A; Yamashita F; Saitoh Y; Yoshimine T
J Neurosurg; 2016 Feb; 124(2):350-8. PubMed ID: 26295919
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
[TBL] [Abstract][Full Text] [Related]
15. The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar Degeneration.
Haanpää RM; Suhonen NM; Hartikainen P; Koivisto AM; Moilanen V; Herukka SK; Hänninen T; Remes AM
Dement Geriatr Cogn Dis Extra; 2015; 5(1):147-54. PubMed ID: 25999981
[TBL] [Abstract][Full Text] [Related]
16. Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women.
Haapalinna F; Paajanen T; Penttinen J; Kokki H; Kokki M; Koivisto AM; Hartikainen P; Solje E; Hänninen T; Remes AM; Herukka SK
Dement Geriatr Cogn Dis Extra; 2016; 6(2):303-12. PubMed ID: 27504119
[TBL] [Abstract][Full Text] [Related]
17. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
Kang K; Ko PW; Jin M; Suk K; Lee HW
J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
[TBL] [Abstract][Full Text] [Related]
19. Computer-based Eye-tracking Analysis of King-Devick Test Differentiates Persons With Idiopathic Normal Pressure Hydrocephalus From Cognitively Unimpaired.
Lehtola JM; Kärkkäinen V; Andberg S; Hannonen S; Rusanen M; Saari T; Korhonen V; Hokkanen L; Hallikainen M; Hänninen T; Kaarniranta K; Bednarik R; Leinonen V; Koivisto AM
Alzheimer Dis Assoc Disord; 2022 Oct-Dec 01; 36(4):340-346. PubMed ID: 36219131
[TBL] [Abstract][Full Text] [Related]
20. Optical Coherence Tomography Revealing Ganglion Cell Loss in Idiopathic Normal Pressure Hydrocephalus.
Eleftheriou A; Huang-Link Y; Lundin F
World Neurosurg; 2021 May; 149():e1061-e1066. PubMed ID: 33444824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
